2 Firms Drive Up To $6B Deal For Nimbus' Psoriasis Drug Biz
Japanese pharmaceutical company Takeda on Tuesday agreed to pay as much as $6 billion to acquire from Nimbus Therapeutics the business unit housing a drug that is being evaluated for the...To view the full article, register now.
Already a subscriber? Click here to view full article